Lu shares are "difficult brothers and brothers"!The stock price of Shengquan Group broke, and the "Unknown" before the Wuming Pharmaceutical Road

Fengkou Finance reporter Tian Liang

Shandong listed companies have a fresh list in a week!

According to Flush iFind data, the Shandong listed company index rose 3.42%last week (August 8th to August 12th).

As of August 12, 2022, a total of 278 A -share listed companies in Shandong, with a total market value of 3.85 trillion yuan. Wanhua Chemical ranked first in the market value list of listed companies in Shandong with 275.890 billion yuan. Haier Zhijia ranked second with 208.712 billion yuan.

Lifting the ban is often called the "flood beast", which is called the A -share market, but it is also rare to collapse into the Shengquan Group.

August 10, 2022 is the first anniversary of the listing of the Shengquan Group Corporation, and it is also the time for the company's 534 million restricted sales shares to lift the ban. This part of the banned shares account for 68.94%of the company's total share capital. Affected by the news of the huge number of lifting shares, on August 10 and 11, the company's two consecutive trading days of the stock price "a word" fell. As of the closing of August 12, the stock price of Shengquan Group Corporation was closed at 21.52 yuan/share. Compared with the listing price of 24.01 yuan/share, the company's stock price has fallen below the issue price. At the beginning of the listing, Shengquan Group reached the highest historical 46 yuan/share, and now the stock price has fallen more than 50%. According to the interim report of the Shengquan Group, the chairman Tang Yilin and his son Tang Diyuan held a total of 19.67%of the shares and were the company's actual controller. As the stock price fell below the issuance price, in this calculation, the market value of Tang Yilin's father and son's shareholding was at least 3.8 billion yuan.

It is worth mentioning that last year, with the listing of Shengquan Group, the wealth value of Tang Yilin's father and son rose high. In the Hurun Rich List in 2021, it became the richest man in Zhangqiu with a value of RMB 6.5 billion. Now that it seems that after the value of more than half of the value, Tang Yilin's richest man's title may not be guaranteed.

As the same brothers and brothers, the road of unnamed medicine was "unknown".

On August 8th, Weiming Pharmaceutical Collection Shenzhen Stock Exchange's follow letter: Recently received investor complaints, saying that Hangzhou Qiangxin admitted to Xiamen with a wholly -owned subsidiary of about 2.9 billion yuan, Xiamen, and obtained about 34%of Xiamen's unnamed shares. Essence With such a large amount of transactions, unnamed medicine did not announce this.

The operating situation of Weiming Medicine itself is also foggy. In 2019, the company was stunned in the mountains due to the growth of the main assets. Since 2017, the financial reports of Weiming Medicine have been reserved by accounting firms for 5 consecutive years. With reference to the financial report in the first half of 2022, the net profit of unnamed medicine fell by 80%year -on -year.

On August 9, Weiming Pharmaceutical issued an announcement that Pan Aihua, the founder and chairman of the company, officially stepped down, and Yue Jialin was the chairman of the company. An era of unnamed medicine was announced, but it is still unknown whether the company can open a new chapter.

According to the comprehensive performance and market hotspots last week of Shandong's 278 listed companies, Fengkou Finance launched the "Shandong Listed Company Hot List". Come and take a look ...

- END -